Pharmaniaga Berhad reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was MYR 848.73 million compared to MYR 761.1 million a year ago. Net income was MYR 1.96 million compared to MYR 0.722 million a year ago. Basic earnings per share from continuing operations was MYR 0.0015 compared to MYR 0.0006 a year ago. Diluted earnings per share from continuing operations was MYR 0.0015 compared to MYR 0.0006 a year ago.
For the six months, sales was MYR 1,729.19 million compared to MYR 1,723.28 million a year ago. Net income was MYR 4.61 million compared to MYR 28.46 million a year ago. Basic earnings per share from continuing operations was MYR 0.0035 compared to MYR 0.0217 a year ago. Diluted earnings per share from continuing operations was MYR 0.0035 compared to MYR 0.0217 a year ago.